nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00416	0.00416	CcSEcCtD
Temozolomide—Embolism—Prednisone—Crohn's disease	0.00411	0.00411	CcSEcCtD
Temozolomide—Gastroenteritis—Mesalazine—Crohn's disease	0.00408	0.00408	CcSEcCtD
Temozolomide—Alopecia—Mercaptopurine—Crohn's disease	0.00407	0.00407	CcSEcCtD
Temozolomide—Deafness—Mesalazine—Crohn's disease	0.00404	0.00404	CcSEcCtD
Temozolomide—Hepatic failure—Mesalazine—Crohn's disease	0.00403	0.00403	CcSEcCtD
Temozolomide—Malnutrition—Mercaptopurine—Crohn's disease	0.00401	0.00401	CcSEcCtD
Temozolomide—Eye pain—Mesalazine—Crohn's disease	0.00401	0.00401	CcSEcCtD
Temozolomide—Thirst—Mesalazine—Crohn's disease	0.0038	0.0038	CcSEcCtD
Temozolomide—Myopathy—Prednisone—Crohn's disease	0.00376	0.00376	CcSEcCtD
Temozolomide—Anaemia—Mercaptopurine—Crohn's disease	0.00371	0.00371	CcSEcCtD
Temozolomide—Leukopenia—Mercaptopurine—Crohn's disease	0.00359	0.00359	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00358	0.00358	CcSEcCtD
Temozolomide—Affect lability—Mesalazine—Crohn's disease	0.00356	0.00356	CcSEcCtD
Temozolomide—Face oedema—Mesalazine—Crohn's disease	0.00349	0.00349	CcSEcCtD
Temozolomide—Mood swings—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Temozolomide—Arthralgia—Mercaptopurine—Crohn's disease	0.00342	0.00342	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Temozolomide—Memory impairment—Prednisone—Crohn's disease	0.00336	0.00336	CcSEcCtD
Temozolomide—Dry skin—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Temozolomide—Oedema—Mercaptopurine—Crohn's disease	0.00328	0.00328	CcSEcCtD
Temozolomide—Breast disorder—Mesalazine—Crohn's disease	0.00327	0.00327	CcSEcCtD
Temozolomide—Pancytopenia—Azathioprine—Crohn's disease	0.00326	0.00326	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00326	0.00326	CcSEcCtD
Temozolomide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00321	0.00321	CcSEcCtD
Temozolomide—Petechiae—Prednisone—Crohn's disease	0.0032	0.0032	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00319	0.00319	CcSEcCtD
Temozolomide—Skin disorder—Mercaptopurine—Crohn's disease	0.00318	0.00318	CcSEcCtD
Temozolomide—Endocrine disorder—Prednisone—Crohn's disease	0.00318	0.00318	CcSEcCtD
Temozolomide—Abdominal distension—Mesalazine—Crohn's disease	0.00315	0.00315	CcSEcCtD
Temozolomide—Dysphagia—Mesalazine—Crohn's disease	0.00313	0.00313	CcSEcCtD
Temozolomide—Anorexia—Mercaptopurine—Crohn's disease	0.00312	0.00312	CcSEcCtD
Temozolomide—Pneumonia—Azathioprine—Crohn's disease	0.00308	0.00308	CcSEcCtD
Temozolomide—Infestation NOS—Azathioprine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Temozolomide—Infestation—Azathioprine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00303	0.00303	CcSEcCtD
Temozolomide—Bronchitis—Mesalazine—Crohn's disease	0.00301	0.00301	CcSEcCtD
Temozolomide—Amenorrhoea—Prednisone—Crohn's disease	0.003	0.003	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00298	0.00298	CcSEcCtD
Temozolomide—Pancytopenia—Mesalazine—Crohn's disease	0.00297	0.00297	CcSEcCtD
Temozolomide—Dysuria—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Temozolomide—Neutropenia—Mesalazine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Temozolomide—Viral infection—Prednisone—Crohn's disease	0.00292	0.00292	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00291	0.00291	CcSEcCtD
Temozolomide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Temozolomide—Pollakiuria—Mesalazine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Temozolomide—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Temozolomide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Temozolomide—Weight increased—Mesalazine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Temozolomide—Weight decreased—Mesalazine—Crohn's disease	0.00283	0.00283	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00283	0.00283	CcSEcCtD
Temozolomide—Pneumonia—Mesalazine—Crohn's disease	0.0028	0.0028	CcSEcCtD
Temozolomide—Infestation NOS—Mesalazine—Crohn's disease	0.00279	0.00279	CcSEcCtD
Temozolomide—Infestation—Mesalazine—Crohn's disease	0.00279	0.00279	CcSEcCtD
Temozolomide—Depression—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00276	0.00276	CcSEcCtD
Temozolomide—Haemoglobin—Azathioprine—Crohn's disease	0.00276	0.00276	CcSEcCtD
Temozolomide—Haemorrhage—Azathioprine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Temozolomide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00273	0.00273	CcSEcCtD
Temozolomide—Stomatitis—Mesalazine—Crohn's disease	0.00272	0.00272	CcSEcCtD
Temozolomide—Urinary tract infection—Mesalazine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Temozolomide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00264	0.00264	CcSEcCtD
Temozolomide—Sinusitis—Mesalazine—Crohn's disease	0.00262	0.00262	CcSEcCtD
Temozolomide—Erythema multiforme—Azathioprine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Temozolomide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Temozolomide—Skin exfoliation—Prednisone—Crohn's disease	0.00252	0.00252	CcSEcCtD
Temozolomide—Haemoglobin—Mesalazine—Crohn's disease	0.00252	0.00252	CcSEcCtD
Temozolomide—Haemorrhage—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Temozolomide—Hepatitis—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Temozolomide—Pharyngitis—Mesalazine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Temozolomide—Immune system disorder—Azathioprine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Temozolomide—Mediastinal disorder—Azathioprine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Temozolomide—Neuropathy—Prednisone—Crohn's disease	0.00248	0.00248	CcSEcCtD
Temozolomide—Urinary tract disorder—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Temozolomide—Oedema peripheral—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Temozolomide—Chills—Azathioprine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Temozolomide—Connective tissue disorder—Mesalazine—Crohn's disease	0.00246	0.00246	CcSEcCtD
Temozolomide—Urethral disorder—Mesalazine—Crohn's disease	0.00245	0.00245	CcSEcCtD
Temozolomide—Alopecia—Azathioprine—Crohn's disease	0.00243	0.00243	CcSEcCtD
Temozolomide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00241	0.00241	CcSEcCtD
Temozolomide—Erythema multiforme—Mesalazine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Temozolomide—Eye disorder—Mesalazine—Crohn's disease	0.00234	0.00234	CcSEcCtD
Temozolomide—Tinnitus—Mesalazine—Crohn's disease	0.00233	0.00233	CcSEcCtD
Temozolomide—Cardiac disorder—Mesalazine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Temozolomide—Angiopathy—Mesalazine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Temozolomide—Immune system disorder—Mesalazine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Temozolomide—Mediastinal disorder—Mesalazine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Temozolomide—Chills—Mesalazine—Crohn's disease	0.00225	0.00225	CcSEcCtD
Temozolomide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00224	0.00224	CcSEcCtD
Temozolomide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00222	0.00222	CcSEcCtD
Temozolomide—Alopecia—Mesalazine—Crohn's disease	0.00221	0.00221	CcSEcCtD
Temozolomide—Thrombophlebitis—Prednisone—Crohn's disease	0.00221	0.00221	CcSEcCtD
Temozolomide—Anaemia—Azathioprine—Crohn's disease	0.00221	0.00221	CcSEcCtD
Temozolomide—Mental disorder—Mesalazine—Crohn's disease	0.00219	0.00219	CcSEcCtD
Temozolomide—Erythema—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Temozolomide—Malaise—Azathioprine—Crohn's disease	0.00216	0.00216	CcSEcCtD
Temozolomide—Leukopenia—Azathioprine—Crohn's disease	0.00214	0.00214	CcSEcCtD
Temozolomide—Vascular purpura—Prednisone—Crohn's disease	0.00214	0.00214	CcSEcCtD
Temozolomide—Dysgeusia—Mesalazine—Crohn's disease	0.00213	0.00213	CcSEcCtD
Temozolomide—Back pain—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Temozolomide—Vomiting—Mercaptopurine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Temozolomide—Rash—Mercaptopurine—Crohn's disease	0.00207	0.00207	CcSEcCtD
Temozolomide—Dermatitis—Mercaptopurine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Temozolomide—Vision blurred—Mesalazine—Crohn's disease	0.00205	0.00205	CcSEcCtD
Temozolomide—Tremor—Mesalazine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Temozolomide—Amnesia—Prednisone—Crohn's disease	0.00204	0.00204	CcSEcCtD
Temozolomide—Myalgia—Azathioprine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Temozolomide—Arthralgia—Azathioprine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Temozolomide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Temozolomide—Anaemia—Mesalazine—Crohn's disease	0.00201	0.00201	CcSEcCtD
Temozolomide—Discomfort—Azathioprine—Crohn's disease	0.00201	0.00201	CcSEcCtD
Temozolomide—Angioedema—Mesalazine—Crohn's disease	0.00199	0.00199	CcSEcCtD
Temozolomide—Purpura—Prednisone—Crohn's disease	0.00199	0.00199	CcSEcCtD
Temozolomide—Malaise—Mesalazine—Crohn's disease	0.00196	0.00196	CcSEcCtD
Temozolomide—Vertigo—Mesalazine—Crohn's disease	0.00196	0.00196	CcSEcCtD
Temozolomide—Leukopenia—Mesalazine—Crohn's disease	0.00195	0.00195	CcSEcCtD
Temozolomide—Nausea—Mercaptopurine—Crohn's disease	0.00195	0.00195	CcSEcCtD
Temozolomide—Infection—Azathioprine—Crohn's disease	0.00194	0.00194	CcSEcCtD
Temozolomide—Palpitations—Mesalazine—Crohn's disease	0.00193	0.00193	CcSEcCtD
Temozolomide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00191	0.00191	CcSEcCtD
Temozolomide—Cough—Mesalazine—Crohn's disease	0.0019	0.0019	CcSEcCtD
Temozolomide—Skin disorder—Azathioprine—Crohn's disease	0.0019	0.0019	CcSEcCtD
Temozolomide—Affect lability—Prednisone—Crohn's disease	0.00188	0.00188	CcSEcCtD
Temozolomide—Hypertension—Mesalazine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Temozolomide—Myalgia—Mesalazine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Temozolomide—Arthralgia—Mesalazine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Temozolomide—Anxiety—Mesalazine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Temozolomide—Face oedema—Prednisone—Crohn's disease	0.00185	0.00185	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00184	0.00184	CcSEcCtD
Temozolomide—Discomfort—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Temozolomide—Dry mouth—Mesalazine—Crohn's disease	0.00181	0.00181	CcSEcCtD
Temozolomide—Mood swings—Prednisone—Crohn's disease	0.00181	0.00181	CcSEcCtD
Temozolomide—Confusional state—Mesalazine—Crohn's disease	0.00179	0.00179	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Temozolomide—Anaphylactic shock—Mesalazine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Temozolomide—Oedema—Mesalazine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Temozolomide—Infection—Mesalazine—Crohn's disease	0.00177	0.00177	CcSEcCtD
Temozolomide—Dry skin—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Temozolomide—Nervous system disorder—Mesalazine—Crohn's disease	0.00174	0.00174	CcSEcCtD
Temozolomide—Hypokalaemia—Prednisone—Crohn's disease	0.00174	0.00174	CcSEcCtD
Temozolomide—Thrombocytopenia—Mesalazine—Crohn's disease	0.00174	0.00174	CcSEcCtD
Temozolomide—Skin disorder—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Temozolomide—Hyperhidrosis—Mesalazine—Crohn's disease	0.00172	0.00172	CcSEcCtD
Temozolomide—Anorexia—Mesalazine—Crohn's disease	0.00169	0.00169	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00169	0.00169	CcSEcCtD
Temozolomide—Muscular weakness—Prednisone—Crohn's disease	0.00169	0.00169	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00169	0.00169	CcSEcCtD
Temozolomide—Abdominal distension—Prednisone—Crohn's disease	0.00167	0.00167	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00162	0.00162	CcSEcCtD
Temozolomide—Sweating increased—Prednisone—Crohn's disease	0.00161	0.00161	CcSEcCtD
Temozolomide—Feeling abnormal—Azathioprine—Crohn's disease	0.00161	0.00161	CcSEcCtD
Temozolomide—Insomnia—Mesalazine—Crohn's disease	0.00161	0.00161	CcSEcCtD
Temozolomide—Paraesthesia—Mesalazine—Crohn's disease	0.0016	0.0016	CcSEcCtD
Temozolomide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.0016	0.0016	CcSEcCtD
Temozolomide—Dyspnoea—Mesalazine—Crohn's disease	0.00159	0.00159	CcSEcCtD
Temozolomide—Somnolence—Mesalazine—Crohn's disease	0.00158	0.00158	CcSEcCtD
Temozolomide—Dyspepsia—Mesalazine—Crohn's disease	0.00156	0.00156	CcSEcCtD
Temozolomide—Neutropenia—Prednisone—Crohn's disease	0.00155	0.00155	CcSEcCtD
Temozolomide—Decreased appetite—Mesalazine—Crohn's disease	0.00155	0.00155	CcSEcCtD
Temozolomide—Abdominal pain—Azathioprine—Crohn's disease	0.00154	0.00154	CcSEcCtD
Temozolomide—Body temperature increased—Azathioprine—Crohn's disease	0.00154	0.00154	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00153	0.00153	CcSEcCtD
Temozolomide—Fatigue—Mesalazine—Crohn's disease	0.00153	0.00153	CcSEcCtD
Temozolomide—Erectile dysfunction—Prednisone—Crohn's disease	0.00152	0.00152	CcSEcCtD
Temozolomide—Pain—Mesalazine—Crohn's disease	0.00152	0.00152	CcSEcCtD
Temozolomide—Constipation—Mesalazine—Crohn's disease	0.00152	0.00152	CcSEcCtD
Temozolomide—Weight increased—Prednisone—Crohn's disease	0.00151	0.00151	CcSEcCtD
Temozolomide—Weight decreased—Prednisone—Crohn's disease	0.0015	0.0015	CcSEcCtD
Temozolomide—Hyperglycaemia—Prednisone—Crohn's disease	0.00149	0.00149	CcSEcCtD
Temozolomide—Depression—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Temozolomide—Feeling abnormal—Mesalazine—Crohn's disease	0.00147	0.00147	CcSEcCtD
Temozolomide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00145	0.00145	CcSEcCtD
Temozolomide—Neuropathy peripheral—Prednisone—Crohn's disease	0.00145	0.00145	CcSEcCtD
Temozolomide—Hypersensitivity—Azathioprine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Temozolomide—Urticaria—Mesalazine—Crohn's disease	0.00141	0.00141	CcSEcCtD
Temozolomide—Abdominal pain—Mesalazine—Crohn's disease	0.00141	0.00141	CcSEcCtD
Temozolomide—Body temperature increased—Mesalazine—Crohn's disease	0.00141	0.00141	CcSEcCtD
Temozolomide—Diarrhoea—Azathioprine—Crohn's disease	0.00134	0.00134	CcSEcCtD
Temozolomide—Haemoglobin—Prednisone—Crohn's disease	0.00133	0.00133	CcSEcCtD
Temozolomide—Haemorrhage—Prednisone—Crohn's disease	0.00132	0.00132	CcSEcCtD
Temozolomide—Hallucination—Prednisone—Crohn's disease	0.00132	0.00132	CcSEcCtD
Temozolomide—Hypersensitivity—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Temozolomide—Connective tissue disorder—Prednisone—Crohn's disease	0.0013	0.0013	CcSEcCtD
Temozolomide—Dizziness—Azathioprine—Crohn's disease	0.00129	0.00129	CcSEcCtD
Temozolomide—Asthenia—Mesalazine—Crohn's disease	0.00128	0.00128	CcSEcCtD
Temozolomide—Pruritus—Mesalazine—Crohn's disease	0.00126	0.00126	CcSEcCtD
Temozolomide—Vomiting—Azathioprine—Crohn's disease	0.00124	0.00124	CcSEcCtD
Temozolomide—Eye disorder—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Temozolomide—Rash—Azathioprine—Crohn's disease	0.00123	0.00123	CcSEcCtD
Temozolomide—Dermatitis—Azathioprine—Crohn's disease	0.00123	0.00123	CcSEcCtD
Temozolomide—Flushing—Prednisone—Crohn's disease	0.00123	0.00123	CcSEcCtD
Temozolomide—Headache—Azathioprine—Crohn's disease	0.00122	0.00122	CcSEcCtD
Temozolomide—Diarrhoea—Mesalazine—Crohn's disease	0.00122	0.00122	CcSEcCtD
Temozolomide—Angiopathy—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Temozolomide—Immune system disorder—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Temozolomide—Dizziness—Mesalazine—Crohn's disease	0.00118	0.00118	CcSEcCtD
Temozolomide—Alopecia—Prednisone—Crohn's disease	0.00117	0.00117	CcSEcCtD
Temozolomide—Mental disorder—Prednisone—Crohn's disease	0.00116	0.00116	CcSEcCtD
Temozolomide—Nausea—Azathioprine—Crohn's disease	0.00116	0.00116	CcSEcCtD
Temozolomide—Erythema—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Temozolomide—Malnutrition—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Temozolomide—Vomiting—Mesalazine—Crohn's disease	0.00113	0.00113	CcSEcCtD
Temozolomide—Rash—Mesalazine—Crohn's disease	0.00112	0.00112	CcSEcCtD
Temozolomide—Dermatitis—Mesalazine—Crohn's disease	0.00112	0.00112	CcSEcCtD
Temozolomide—Headache—Mesalazine—Crohn's disease	0.00111	0.00111	CcSEcCtD
Temozolomide—Vision blurred—Prednisone—Crohn's disease	0.00109	0.00109	CcSEcCtD
Temozolomide—Ill-defined disorder—Prednisone—Crohn's disease	0.00107	0.00107	CcSEcCtD
Temozolomide—Anaemia—Prednisone—Crohn's disease	0.00107	0.00107	CcSEcCtD
Temozolomide—Agitation—Prednisone—Crohn's disease	0.00106	0.00106	CcSEcCtD
Temozolomide—Nausea—Mesalazine—Crohn's disease	0.00106	0.00106	CcSEcCtD
Temozolomide—Angioedema—Prednisone—Crohn's disease	0.00105	0.00105	CcSEcCtD
Temozolomide—Malaise—Prednisone—Crohn's disease	0.00104	0.00104	CcSEcCtD
Temozolomide—Vertigo—Prednisone—Crohn's disease	0.00104	0.00104	CcSEcCtD
Temozolomide—Convulsion—Prednisone—Crohn's disease	0.000999	0.000999	CcSEcCtD
Temozolomide—Hypertension—Prednisone—Crohn's disease	0.000995	0.000995	CcSEcCtD
Temozolomide—Myalgia—Prednisone—Crohn's disease	0.000981	0.000981	CcSEcCtD
Temozolomide—Arthralgia—Prednisone—Crohn's disease	0.000981	0.000981	CcSEcCtD
Temozolomide—Anxiety—Prednisone—Crohn's disease	0.000978	0.000978	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000974	0.000974	CcSEcCtD
Temozolomide—Discomfort—Prednisone—Crohn's disease	0.000969	0.000969	CcSEcCtD
Temozolomide—Oedema—Prednisone—Crohn's disease	0.000941	0.000941	CcSEcCtD
Temozolomide—Anaphylactic shock—Prednisone—Crohn's disease	0.000941	0.000941	CcSEcCtD
Temozolomide—Infection—Prednisone—Crohn's disease	0.000934	0.000934	CcSEcCtD
Temozolomide—Nervous system disorder—Prednisone—Crohn's disease	0.000922	0.000922	CcSEcCtD
Temozolomide—Skin disorder—Prednisone—Crohn's disease	0.000914	0.000914	CcSEcCtD
Temozolomide—Hyperhidrosis—Prednisone—Crohn's disease	0.000909	0.000909	CcSEcCtD
Temozolomide—Anorexia—Prednisone—Crohn's disease	0.000897	0.000897	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000857	0.000857	CcSEcCtD
Temozolomide—Insomnia—Prednisone—Crohn's disease	0.000851	0.000851	CcSEcCtD
Temozolomide—Paraesthesia—Prednisone—Crohn's disease	0.000845	0.000845	CcSEcCtD
Temozolomide—Dyspepsia—Prednisone—Crohn's disease	0.000828	0.000828	CcSEcCtD
Temozolomide—Decreased appetite—Prednisone—Crohn's disease	0.000818	0.000818	CcSEcCtD
Temozolomide—Fatigue—Prednisone—Crohn's disease	0.000811	0.000811	CcSEcCtD
Temozolomide—Constipation—Prednisone—Crohn's disease	0.000804	0.000804	CcSEcCtD
Temozolomide—Feeling abnormal—Prednisone—Crohn's disease	0.000775	0.000775	CcSEcCtD
Temozolomide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000769	0.000769	CcSEcCtD
Temozolomide—Urticaria—Prednisone—Crohn's disease	0.000747	0.000747	CcSEcCtD
Temozolomide—Abdominal pain—Prednisone—Crohn's disease	0.000744	0.000744	CcSEcCtD
Temozolomide—Body temperature increased—Prednisone—Crohn's disease	0.000744	0.000744	CcSEcCtD
Temozolomide—Hypersensitivity—Prednisone—Crohn's disease	0.000693	0.000693	CcSEcCtD
Temozolomide—Asthenia—Prednisone—Crohn's disease	0.000675	0.000675	CcSEcCtD
Temozolomide—Pruritus—Prednisone—Crohn's disease	0.000666	0.000666	CcSEcCtD
Temozolomide—Diarrhoea—Prednisone—Crohn's disease	0.000644	0.000644	CcSEcCtD
Temozolomide—Dizziness—Prednisone—Crohn's disease	0.000622	0.000622	CcSEcCtD
Temozolomide—Vomiting—Prednisone—Crohn's disease	0.000598	0.000598	CcSEcCtD
Temozolomide—Rash—Prednisone—Crohn's disease	0.000593	0.000593	CcSEcCtD
Temozolomide—Dermatitis—Prednisone—Crohn's disease	0.000593	0.000593	CcSEcCtD
Temozolomide—Headache—Prednisone—Crohn's disease	0.000589	0.000589	CcSEcCtD
Temozolomide—Nausea—Prednisone—Crohn's disease	0.000559	0.000559	CcSEcCtD
